Skip to main content
Top
Published in: Internal and Emergency Medicine 8/2013

01-12-2013 | IM - ORIGINAL

Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus

Authors: Marta Vadacca, Enrico M. Zardi, Domenico Margiotta, Amelia Rigon, Fabio Cacciapaglia, Luisa Arcarese, Francesca Buzzulini, Antonio Amoroso, Antonella Afeltra

Published in: Internal and Emergency Medicine | Issue 8/2013

Login to get access

Abstract

The purpose of the present study was to determine levels of adipokines and their relationship with stiffness parameters and disease activity index in SLE patients in comparison with healthy controls. Sixty SLE patients and 29 control subjects were enrolled in the study. Serum leptin and adiponectin levels were determined by commercial sandwich ELISA kits. Colour-coded carotid duplex sonography was performed using a Siemens SONOLINE Antares machine equipped with linear 5–13 MHz. SLEDAI, ECLAM and SLICC were evaluated in all patients. Data were analysed by software for statistical analysis (Prism 5.0). Median leptin is higher among SLE patients compared with controls (p 0.035). Median values of vascular stiffness and PSEM are increased in SLE compared with controls (p = 0.0003 and p = 0.007). Vascular strain and vascular distensibility are lower in SLE patients in comparison with controls (p = 0.0001 and p = 0.0006, respectively). Considering SLE patients, leptin levels correlate with vascular stiffness (r = 0.64, p < 0.0001) and PSEM (r = 0.63, p < 0.0001). Adiponectin levels correlate with vascular strain (r = 0.28, p 0.039) and negatively correlate with vascular stiffness (r = −0.38, p 0.039). Leptin levels correlate with disease activity (SLEDAI and ECLAM) and cumulative damage (SLICC) indexes. This study demonstrates higher values of leptin in SLE patients. Moreover, SLE patients show increased levels of vascular stiffness and PSEM and reduced values of vascular strain and distensibility. These results globally indicate a decline in arterial elasticity. We find a positive correlation of leptin with stiffness parameters. According to its atheroprotective action, adiponectin inversely correlates with stiffness parameters.
Literature
1.
go back to reference Abu-Shakra M, Codish S, Zeller L, Wolak T, Sukenik S (2008) Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience. Isr Med Assoc J 10:43–44PubMed Abu-Shakra M, Codish S, Zeller L, Wolak T, Sukenik S (2008) Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience. Isr Med Assoc J 10:43–44PubMed
2.
go back to reference Cacciapaglia F, Zardi EM, Coppolino G, Buzzulini F, Margiotta D, Arcarese L et al (2009) Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus 18:249–256PubMedCrossRef Cacciapaglia F, Zardi EM, Coppolino G, Buzzulini F, Margiotta D, Arcarese L et al (2009) Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus 18:249–256PubMedCrossRef
3.
go back to reference Roman MJ, Shanker BA, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Eng J Med 349:2399–2406CrossRef Roman MJ, Shanker BA, Davis A et al (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Eng J Med 349:2399–2406CrossRef
4.
go back to reference El Magadmi M, Bodill H, Ahmad Y et al (2004) Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110:399–404PubMedCrossRef El Magadmi M, Bodill H, Ahmad Y et al (2004) Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 110:399–404PubMedCrossRef
5.
go back to reference McMahon M, Grossman J, Skaggs B, Fitzgerald J, Sahakian L, Ragavendra N et al (2009) Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum 30:2428–2437CrossRef McMahon M, Grossman J, Skaggs B, Fitzgerald J, Sahakian L, Ragavendra N et al (2009) Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum 30:2428–2437CrossRef
6.
go back to reference Ahmad Y, Shelmerdine J, Bodill H, Lunt M, Pattrick MG, Teh LS et al (2007) Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology (Oxford) 46:983–988CrossRef Ahmad Y, Shelmerdine J, Bodill H, Lunt M, Pattrick MG, Teh LS et al (2007) Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology (Oxford) 46:983–988CrossRef
7.
go back to reference Doria A, Shoenfeld Y, Wu R (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62:1071–1077PubMedCrossRef Doria A, Shoenfeld Y, Wu R (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62:1071–1077PubMedCrossRef
8.
go back to reference Pereira RM, de Carvalho JF, Bonfá E (2009) Metabolic syndrome in rheumatological diseases. Autoimmun Rev 8:415–419PubMedCrossRef Pereira RM, de Carvalho JF, Bonfá E (2009) Metabolic syndrome in rheumatological diseases. Autoimmun Rev 8:415–419PubMedCrossRef
9.
go back to reference Vadacca M, Margiotta D, Rigon A, Cacciapaglia F, Coppolino G, Amoroso A et al (2009) Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol 36:295–297PubMedCrossRef Vadacca M, Margiotta D, Rigon A, Cacciapaglia F, Coppolino G, Amoroso A et al (2009) Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol 36:295–297PubMedCrossRef
10.
go back to reference Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintani A, Raggi P et al (2007) High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66:208–214PubMedCrossRef Chung CP, Avalos I, Oeser A, Gebretsadik T, Shintani A, Raggi P et al (2007) High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66:208–214PubMedCrossRef
11.
go back to reference Ohman MK, Wright AP, Wickenheiser KJ, Luo W, Eitzman DT (2009) Visceral adipose tissue and atherosclerosis. Curr Vasc Pharmacol 7:169–179PubMedCrossRef Ohman MK, Wright AP, Wickenheiser KJ, Luo W, Eitzman DT (2009) Visceral adipose tissue and atherosclerosis. Curr Vasc Pharmacol 7:169–179PubMedCrossRef
12.
go back to reference Calabrò P, Golia E, Maddaloni V, Malvezzi M, Casillo B, Marotta C et al (2009) Adipose tissue mediated inflammation: the missing link between obesity and cardiovascular disease? Intern Emerg Med 4:25–34PubMedCrossRef Calabrò P, Golia E, Maddaloni V, Malvezzi M, Casillo B, Marotta C et al (2009) Adipose tissue mediated inflammation: the missing link between obesity and cardiovascular disease? Intern Emerg Med 4:25–34PubMedCrossRef
13.
go back to reference Antuna-Puente B, Feve B, Fellahi S, Bastard JP (2008) Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 34:2–11PubMedCrossRef Antuna-Puente B, Feve B, Fellahi S, Bastard JP (2008) Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 34:2–11PubMedCrossRef
14.
go back to reference Lambert M, O’Loughlin J, Delvin EE, Levy E, Chiolero A, Paradis G (2009) Association between insulin, leptin, adiponectin and blood pressure in youth. J Hypertens 27:1025–1032PubMedCrossRef Lambert M, O’Loughlin J, Delvin EE, Levy E, Chiolero A, Paradis G (2009) Association between insulin, leptin, adiponectin and blood pressure in youth. J Hypertens 27:1025–1032PubMedCrossRef
15.
go back to reference Bo S, Gambino R, Gentile L, Pagano G, Rosato R, Saracco GM et al (2009) High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study. J Hypertens 27:102–108PubMedCrossRef Bo S, Gambino R, Gentile L, Pagano G, Rosato R, Saracco GM et al (2009) High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study. J Hypertens 27:102–108PubMedCrossRef
16.
go back to reference Tilg H, Moshen AR (2006) Adipocytochinines: mediators linking adipose tissue, inflammation and immunity. Nature 6:772–783 Tilg H, Moshen AR (2006) Adipocytochinines: mediators linking adipose tissue, inflammation and immunity. Nature 6:772–783
17.
go back to reference Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288:2031–2041CrossRef Lau DCW, Dhillon B, Yan H, Szmitko PE, Verma S (2005) Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288:2031–2041CrossRef
18.
go back to reference Lam QL, Lu L (2007) Role of leptin in Immunity. Cellular & Molecular Immunology 4:1–13 Lam QL, Lu L (2007) Role of leptin in Immunity. Cellular & Molecular Immunology 4:1–13
19.
go back to reference Bełtowski J (2006) Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 24:789–801PubMedCrossRef Bełtowski J (2006) Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 24:789–801PubMedCrossRef
20.
21.
go back to reference Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N (2001) Plasmaleptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052–3056PubMedCrossRef Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N (2001) Plasmaleptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052–3056PubMedCrossRef
22.
go back to reference Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and metabolic syndrome. J Clin Invest 116:1784–1792PubMedCrossRef Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and metabolic syndrome. J Clin Invest 116:1784–1792PubMedCrossRef
24.
go back to reference Tziomalos K, Tziomalos K, Sivanadarajah N, Mikhailidis DP, Boumpas DT, Seifalian AM (2008) Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk? Clin Exp Rheumatol 26:1134–1145PubMed Tziomalos K, Tziomalos K, Sivanadarajah N, Mikhailidis DP, Boumpas DT, Seifalian AM (2008) Increased risk of vascular events in systemic lupus erythematosus: is arterial stiffness a predictor of vascular risk? Clin Exp Rheumatol 26:1134–1145PubMed
25.
go back to reference Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113:657–663PubMedCrossRef Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA et al (2006) Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113:657–663PubMedCrossRef
26.
go back to reference Parati G, Bernardi L (2006) How to assess arterial compliance in humans. J Hypertens 24:1009–1012PubMedCrossRef Parati G, Bernardi L (2006) How to assess arterial compliance in humans. J Hypertens 24:1009–1012PubMedCrossRef
27.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef
28.
go back to reference Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al (2007) Guidelines for the management of arterial hypertension: the task force for the managementof arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 25:1105–1187PubMedCrossRef Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al (2007) Guidelines for the management of arterial hypertension: the task force for the managementof arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 25:1105–1187PubMedCrossRef
29.
go back to reference Griffiths B, Mosca M, Gordon C (2005) Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 19:685–708PubMedCrossRef Griffiths B, Mosca M, Gordon C (2005) Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 19:685–708PubMedCrossRef
30.
go back to reference Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupusanticoagulants: an update On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 74:1185–1190PubMed Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupusanticoagulants: an update On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 74:1185–1190PubMed
31.
go back to reference Von Feldt JM (2008) The cardiovascular threat of lupus. Nat Clin Pract Rheumatol 4:505CrossRef Von Feldt JM (2008) The cardiovascular threat of lupus. Nat Clin Pract Rheumatol 4:505CrossRef
32.
go back to reference Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW et al (2009) Atherosclerosis prevention in pediatric lupus erythematosus investigators. prematureatherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotidintima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosuscohort. Arthritis Rheum 60:1496–1507PubMedCrossRef Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW et al (2009) Atherosclerosis prevention in pediatric lupus erythematosus investigators. prematureatherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotidintima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosuscohort. Arthritis Rheum 60:1496–1507PubMedCrossRef
33.
go back to reference De Leeuw K, Smit AJ, de Groot E, van Roon AM, Kallenberg CG, Bijl M. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis 2009; 25 De Leeuw K, Smit AJ, de Groot E, van Roon AM, Kallenberg CG, Bijl M. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis 2009; 25
34.
go back to reference Cypiene A, Kovaite M, Venalis A, Dadoniene J, Rugiene R, Petrulioniene Z et al (2009) Arterialwall dysfunction in systemic lupus erythematosus. Lupus 18:522–529PubMedCrossRef Cypiene A, Kovaite M, Venalis A, Dadoniene J, Rugiene R, Petrulioniene Z et al (2009) Arterialwall dysfunction in systemic lupus erythematosus. Lupus 18:522–529PubMedCrossRef
35.
go back to reference Shang Q, Tam LS, Li EK, Yip GW, Yu CM (2008) Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Lupus 17:1096–1102PubMedCrossRef Shang Q, Tam LS, Li EK, Yip GW, Yu CM (2008) Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus. Lupus 17:1096–1102PubMedCrossRef
36.
go back to reference Brodszki J, Bengtsson C, Länne T, Nived O, Sturfelt G, Marsál K (2004) Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus. Lupus 13:917–923PubMedCrossRef Brodszki J, Bengtsson C, Länne T, Nived O, Sturfelt G, Marsál K (2004) Abnormal mechanical properties of larger arteries in postmenopausal women with systemic lupus erythematosus. Lupus 13:917–923PubMedCrossRef
37.
go back to reference Chow PC, Ho MH, Lee TL, Lau YL, Cheung YF (2007) Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol 6:1345–1352 Chow PC, Ho MH, Lee TL, Lau YL, Cheung YF (2007) Relation of arterial stiffness to left ventricular structure and function in adolescents and young adults with pediatric-onset systemic lupus erythematosus. J Rheumatol 6:1345–1352
38.
go back to reference McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, et al. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis 2011; June 13 McMahon M, Skaggs BJ, Sahakian L, Grossman J, FitzGerald J, et al. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis 2011; June 13
39.
go back to reference Vadacca M, Margiotta D, Sambataro G, Cacciapaglia F, Rigon A, Buzzulini F, Afeltra A (2010) Leptin levels in patients affected by Sjogren’s syndrome and systemic lupus erythematosus. Ann Rheum Dis 69(Suppl3):573 Vadacca M, Margiotta D, Sambataro G, Cacciapaglia F, Rigon A, Buzzulini F, Afeltra A (2010) Leptin levels in patients affected by Sjogren’s syndrome and systemic lupus erythematosus. Ann Rheum Dis 69(Suppl3):573
Metadata
Title
Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus
Authors
Marta Vadacca
Enrico M. Zardi
Domenico Margiotta
Amelia Rigon
Fabio Cacciapaglia
Luisa Arcarese
Francesca Buzzulini
Antonio Amoroso
Antonella Afeltra
Publication date
01-12-2013
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 8/2013
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0726-0

Other articles of this Issue 8/2013

Internal and Emergency Medicine 8/2013 Go to the issue

CE - LETTER TO THE EDITOR

A victim of the Occam’s razor

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.